NGAL Rapid ELISA Kit
NGAL (neutrophil gelatinase associated lipocalin) is a new early marker for acute kidney injury. NGAL levels rise within 2 hours after injury and has been used to assess patients after cardiac surgery,renal transplantation and procedures involving the use of i.v. contrast media. Our CE-IVD-marked NGAL Rapid ELISA Kit measures human NGAL in urine, plasma or serum. The positive predictive value for acute renal failure is over 90%.
A new addition to our NGAL portfolio: Anti-NGAL (mouse) antibody pair
The new monoclonal antibodies ABS 043-10 and ABS 043-29 can be used to detect mouse NGAL and form an ELISA sandwich pair with ABS 043-10 as the capture antibody and biotinylated ABS 043-29 (ABS 043-29B) as the detection antibody.
Our anti-mouse NGAL antibodies will complement our human and rat NGAL ELISA Kit and our monkey NGAL antibodies and enable researchers to measure NGAL in the most common pre-clinical animal models.Go to the mouse NGAL antibodies
BioPorto Diagnostics has also developed an antibody sandwich ELISA pair for detection of monkey (Cynomolgus) NGAL. Click here to view the product specification.
Rat NGAL ELISA Kit launched
NGAL determination allows kidney injury to be detected almost as soon as it occurs. Rats are among the most frequently used laboratory animals for research on kidney damage. The rat NGAL test can thus be used in the development of new treatments for kidney damage, to detect nephrotoxic side effects of new drugs, and for basic science research on kidney injury and kidney diseases.
It is therefore expected that the use of NGAL as a toxicological marker of kidney damage in rats could prove to be of considerable importance in the preclinical evaluation of new pharmacological products, as it is much cheaper and easier to determine NGAL than to carry out a microscopic examination of the kidney itself, which is the typical experimental end-point today.
